Endoscopic treatment of clinically symptomatic leaks of thoracic esophageal anastomoses
- PMID: 10625803
- DOI: 10.1016/s0016-5107(00)70391-9
Endoscopic treatment of clinically symptomatic leaks of thoracic esophageal anastomoses
Abstract
Background: The mortality of thoracic anastomotic leakage following esophageal reconstruction has been reported to be as high as 60%. Early septic fulminant suture line leaks require rethoracotomy. In addition, however, clinically symptomatic leaks may also occur 2 to 7 days after resection of the esophagus.
Methods: Among 80 esophageal reconstructions performed between January 1994 and July 1998, a total of 7 (8.75%) clinically apparent leaks of thoracic anastomoses were observed. The standard treatment consisted of endoscopic lavage, drainage and subsequent closure of the defect by repeated intraluminal and submucosal applications of fibrin glue. In 2 patients a novel approach permitting rapid closure by plugging the fistula with a Vicryl-cylinder was tried. In 4 patients the effect of endoscopic treatment on the HLA-DR expression on monocytes was investigated and compared to 6 patients with intact anastomoses.
Results: All 7 patients were successfully treated via endoscopy. The cylinder plug achieved immediate closure of the leak. The measured change in HLA-DR expression reflected the improvement in the inflammatory response and thus documented the success of endoscopic treatment.
Conclusions: Endoscopic management of thoracic leakages represents a safe and relatively noninvasive therapeutic option.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials